Image

PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC).

PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC).

Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

This prospective study will examine eosinophils in various biological materials to compare the detection in those materials and ascertain the prognostic and predictive role of eosinophils in untreated non-small cell lung cancer patient.

Eligibility

Inclusion Criteria:

  • o All stages of NSCLC
    • Stage III-IV NSCLC eligible for ICI treatment
    • 18 years or older; non pregnant women
    • in stage III-IV: no previous ICI and before ICI (mono- or combination therapy) initiation
    • Signed informed consent
    • Clinical, biological and radiological evaluation at the CHU de Liège for at least 6 months following treatment initiation

Exclusion Criteria:

  • Probable noncompliance with the follow-up requirements of the study (psychiatric condition, socio-economic factors)
  • Inclusion in a clinical study contraindicating the enrolment in the PROTEON study

Study details
    Non-small Cell Lung Cancer

NCT05602259

Centre Hospitalier Universitaire de Liege

15 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.